Original ArticleSafety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial
Under an Elsevier user license
open archive
Keywords
Cystic fibrosis
Tobramycin inhalation powder (TIP™)
Pseudomonas aeruginosa
Lung infection
Cited by (0)
- 1
On behalf of the EAGER Study Investigators.
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.